SCHEMBL1286573

SCHEMBL1286573

CCOC(=O)c1c(C(F)(F)F)nn2c(=O)cc(-c3ccc(OC)cc3)[nH]c12

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PLAT P00750 3/20 0.51
POLB P06746 3/20 0.44
RXFP1 Q9HBX9 1/20 0.44
GAA P10253 2/20 0.43
SMN1; SMN2 Q16637 2/20 0.42
HTT P42858 1/20 0.42
MAPK10 P53779 1/20 0.42
MAPT P10636 4/20 0.41
L3MBTL1 Q9Y468 2/20 0.41
NPC1 O15118 1/20 0.41
RAB9A P51151 1/20 0.41
PDE4D Q08499 1/20 0.41
GRM6 O15303 1/20 0.41
ALDH1A1 P00352 4/20 0.41
KMT2A Q03164 2/20 0.41
LMNA P02545 1/20 0.41
TP53 P04637 2/20 0.41
KDM4E B2RXH2 2/20 0.41
ALPL P05186 1/20 0.40
ALPI P09923 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1278820 0.89 PLAT (0.53) PLATPOLBGAASMN1; SMN2HTT
SCHEMBL1614723 0.87 POLB (0.50) PLATPOLBGAASMN1; SMN2HTT
SCHEMBL1286570 0.86 PLAT (0.50) PLATRXFP1GAASMN1; SMN2HTT
SCHEMBL1279373 0.81 PLAT (0.59) PLATPOLBMAPTL3MBTL1ALDH1A1
SCHEMBL1286606 0.80 PLAT (0.52) PLATL3MBTL1ALDH1A1KDM4EHPGD
SCHEMBL15926309 0.80 PLAT (0.47) PLATMAPTRAB9APDE4DALDH1A1
SCHEMBL1279172 0.80 PLAT (0.51) PLATSMN1; SMN2NPC1ALDH1A1KMT2A
SCHEMBL1286578 0.80 PLAT (0.52) PLATL3MBTL1ALDH1A1KDM4EHPGD
SCHEMBL1278684 0.79 PLAT (0.56) PLATMAPTALDH1A1KDM4EHPGD
SCHEMBL1286584 0.78 PLAT (0.56) PLATALDH1A1KDM4EHPGDHSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8796285-B2 Pyrazolo [1,5-a]-pyrimidones derivatives and pharmaceutical compositions and uses thereof HEBEI MEDICAL UNIVERSITY (CN) 2014-08-05 US disclosed
US-8796285-B2 Pyrazolo [1,5-a]-pyrimidones derivatives and pharmaceutical compositions and uses thereof HEBEI MEDICAL UNIVERSITY (CN) 2014-08-05 US disclosed
US-20120088775-A1 Pyrazolo-[1,5-a]-Pyrimidones Derivatives and Pharmaceutical Compositions and Uses Thereof PEKING UNIVERSITY (CN) 2012-04-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120088775-A1 Pyrazolo-[1,5-a]-Pyrimidones Derivatives and Pharmaceutical Compositions and Uses Thereof KCNJ2, KCNQ5, KCNJ11 PLAT 1286/4885POLB 2845/4885RXFP1 2164/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.